Assessing a care system to prevent dependency in elderly hospitalized patients
Feasibility Assessment of Implementing a Care System to PREVENT Iatrogenic Dependency (ID) Related to Hospitalization in People Over 70 Years : Pilot Study. PREVENT-ID
This study tests a new care system designed to help older hospitalized patients stay independent and see if it works better than regular care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 76 (estimated) |
| Ages | 70 Years and up |
| Sex | All |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 1 site (Toulouse) |
| Trial ID | NCT06173154 on ClinicalTrials.gov |
What this trial studies
This study evaluates the feasibility of implementing a specialized care system aimed at preventing iatrogenic dependency in patients aged 70 and older during hospitalization. Two care units are involved: one follows routine care practices while the other utilizes the new prevention-focused care system, with caregivers receiving specific training on preventing dependency. The study compares the outcomes of patients in both units to assess the effectiveness of the intervention in reducing dependency levels.
Who should consider this trial
Good fit: Ideal candidates for this study are hospitalized individuals aged 70 and older who are expected to stay for at least 48 hours.
Not a fit: Patients in end-of-life situations or those with severe dependency prior to hospitalization may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the risk of dependency in elderly patients during hospital stays, improving their overall health outcomes.
How similar studies have performed: While the specific approach may be novel, similar studies focusing on preventing dependency in elderly patients during hospitalization have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
inclusion criteria: * Patient hospitalized for at least 48 hours in the participating center * Persons affiliated to a social security system, * The patient, his trusted person or a relative present during his hospitalization have not expressed opposition to his participation in the research.. exclusion criteria: * End of life situation, * ADL at 0/6 for 15 days before hospitalization. * Refusal to participate, * Patient under judicial protection
Where this trial is running
Toulouse
- CHU de Toulouse — Toulouse, France (Recruiting)
Study contacts
- Study coordinator: Caroline BERBON
- Email: berbon.c@chu-toulouse.fr
- Phone: 05 61 77 70 17
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.